strong finish outlook continu showcas posit oper momentum
deliv strong finish ebitda beat formal ebitda
guidanc repres growth lt target combin anoth
quarter impress same-stor adjust admiss volum outlook
remain solid foot driven high qualiti end-market growth continu
market share gain price revenu adj admiss quarter came
prior-year trend management attribut overal shift mix lower
acuiti ss medic admiss outpac ss surgeri wide
margin final cost remain well control especi opex line unit
cost trend expect increas rang similar recent year
littl flu impact management think flu bp impact ss
emerg room visit littl impact strong ss inpati
admiss modest price management instead attribut softer price
mix acuiti medic admiss outpac inpati surgeri
wide margin minim flu impact gener consist hospit
preview probabl good indic well see rest
reiter ow follow result rais ebitda estim
mn mn estim mn mn
addit solid earn growth outlook exit strong balanc
sheet allow plenti flexibl deploy capit said rais price target
base multipl higher ebitda
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
idc link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight largest for-profit
hospit system unit state compani
expos local market high weight averag
popul growth maintain high share within
market provid strong negoti leverag
payer hca acceler capit spend plan
continu drive increment growth
next year
ebitda upsid capit deploy
greater anticip organ growth
volum weaker anticip ebitda
exit year deliv strongest same-stor quarterli volum sinc
benefit flu benefit er volum bp otherwis minim impact
quarter price target driven overal shift mix lower
acuiti medic admiss outpac inpati surgeri signific
margin howev cost remain well control especi opex line management
think unit cost includ labor increas similar recent year
addit strong oper trend hca leverag ratio lowest level
past decad low-end target allow increas share
repurchas author bn quarterli dividend
addit management note expect complet coupl small deal near-
term pipelin balanc sheet capac execut much larger acquisit
incom statement wage oper earn incom incom attribut nci pre-tax tax tax rate excl incom share ep barclay healthcar inc
initi guidancev bpsrev/ bpsopex bpscash bp barclay healthcar inc
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
